Delivery Order SPE2DB24D3015-SPE2DB25FFZEL

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,990.06 firm fixed-price contract is for the delivery of Vraylar 1.5 mg capsules. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,675.13, is for the delivery of Vraylar 1.5 mg capsules. The contract is a firm fixed-price delivery order with a performance period ending on December 31, 2024. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,232.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,452.90, is for the delivery of Vraylar 3 mg capsules over the period ending on May 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,620.17, is for the supply of Vraylar 4.5 mg capsules. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 10, 2025. It is not associated with any set-aside requirements. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,157.57 firm-fixed-price contract is for the supply of 4.5 mg Vraylar capsules. The contract has an ultimate completion date of April 23, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The contract has a ceiling value of $26,992.52 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type without any set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these prescription medications to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.83, is for the delivery of Vraylar 1.5 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, with a ceiling value of $27,831.47 and a period of performance through April 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, with a ceiling value of $24,198.57 and a period of performance through April 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZEL
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,253.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. The contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/31/25, 10:05 AM